Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Olaparib + Durvalumab for Small Cell Lung Cancer
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a combination of drugs to see if it can help people with a specific type of lung cancer that has transformed into another cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.